GlassScriptPhysician profile
Lilian Sababa
NPI 1891806329
$2,767.10
in general payments reported to CMS, 2019-2025
10 companies · $544 in 2025
The $544 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $146 · 2021: $275 · 2022: $357 · 2023: $736 · 2024: $376 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,655.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $519.66 | 2023-2024 | Dupixent |
| Sanofi Pasteur INC. | $510.38 | 2019-2025 | |
| Pfizer INC. | $482.51 | 2019-2025 | |
| Glaxosmithkline, LLC. | $373.06 | 2019-2024 | Bexsero, Rotarix, Pediarix |
| Genzyme Corporation | $261.72 | 2023-2025 | |
| Cranial Technologies, INC | $235.29 | 2019-2025 | Doc Band |
| Kowa Pharmaceuticals America, INC. | $159.23 | 2025 | Zoryve |
| Merck Sharp & Dohme LLC | $109.23 | 2019-2023 | Vaxelis, Vaxneuvance, Rotateq |
| Sobi, INC | $102.40 | 2019-2023 | |
| Cognoa, INC. | $13.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lilian Sababa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.